9 Meters Biopharma, Inc. Sustainability Profile
9 Meters Biopharma, Inc., headquartered in the United States, is a pioneering biotechnology company focused on developing innovative therapies for patients with rare gastrointestinal diseases. Founded in 2018, the company has quickly established itself in the biopharmaceutical industry, particularly in the areas of drug development and clinical research. With a robust pipeline that includes unique oral therapies, 9 Meters Biopharma is dedicated to addressing unmet medical needs in conditions such as short bowel syndrome and celiac disease. Their flagship product, a novel treatment for short bowel syndrome, showcases their commitment to advancing patient care through cutting-edge science. Recognised for its rapid progress and strategic partnerships, 9 Meters Biopharma is positioned as a leader in the biopharma sector, striving to improve the quality of life for patients worldwide.
DitchCarbon Score
How does 9 Meters Biopharma, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
9 Meters Biopharma, Inc.'s score of 17 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
9 Meters Biopharma, Inc.'s reported carbon emissions
In 2024, 9 Meters Biopharma, Inc. reported carbon emissions of approximately 949,000 kg CO2e, primarily from Scope 2 emissions. This figure reflects a slight increase from the previous year, 2023, when emissions were about 937,000 kg CO2e. The company has not disclosed any Scope 1 or Scope 3 emissions data, indicating a focus on indirect emissions associated with purchased electricity, steam, heating, and cooling. Despite the absence of specific reduction targets or initiatives, 9 Meters Biopharma is committed to addressing its carbon footprint. The company has not inherited emissions data from a parent organisation, and all reported figures are directly attributed to its operations. As part of its climate strategy, 9 Meters Biopharma is expected to align with industry standards and best practices in sustainability, although no formal climate pledges or targets have been established at this time.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | - | - |
| Scope 2 | 937,000 | 000,000 |
| Scope 3 | - | - |
How Carbon Intensive is 9 Meters Biopharma, Inc.'s Industry?
How Carbon Intensive is 9 Meters Biopharma, Inc.'s Location?
9 Meters Biopharma, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
9 Meters Biopharma, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
